URVIN was derived from peripheral blood of a terminally ill 52-year-old male myeloma patient with secondary plasma cell leukemia, and the clinical parameters measured at sampling were albumin: 32 g/L, and IgG-kappa: 2.8 g/L. Here, ALB is linked to plasma cell myeloma.